Page last updated: 2024-08-16

propranolol and eptifibatide

propranolol has been researched along with eptifibatide in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Akhtar, A; Anzuini, A; Birnbaum, Y; Chamoun, A; Gupta, R; Kumar, D; Lev, E; Lui, C; McGehee, T; Osman, A; Paniagua, O; Pohwani, A; Schwarz, ER; Uretsky, BF; Wang, FW	1

Reviews

1 review(s) available for propranolol and eptifibatide

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for propranolol and eptifibatide

Article	Year
Distal myocardial protection with intracoronary beta blocker when added to a Gp IIb/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2008, Oct-01, Volume: 72, Issue:4 Topics: Adrenergic beta-Antagonists; Aged; Angioplasty, Balloon, Coronary; Biomarkers; Coronary Artery Disease; Creatine Kinase, MB Form; Double-Blind Method; Drug Administration Routes; Drug Therapy, Combination; Eptifibatide; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Propranolol; Prospective Studies; Time Factors; Treatment Outcome	2008

Article

Year

Distal myocardial protection with intracoronary beta blocker when added to a Gp IIb/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2008, Oct-01, Volume: 72, Issue:4

Topics: Adrenergic beta-Antagonists; Aged; Angioplasty, Balloon, Coronary; Biomarkers; Coronary Artery Disease; Creatine Kinase, MB Form; Double-Blind Method; Drug Administration Routes; Drug Therapy, Combination; Eptifibatide; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Propranolol; Prospective Studies; Time Factors; Treatment Outcome

2008

Other Studies

1 other study(ies) available for propranolol and eptifibatide

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008